Archive · 1 Jan 2026

Vijay Kedia Invests in Struggling Mangalam Drugs

Vijay Kedia Invests in Struggling Mangalam Drugs

Vijay Kedia, a well-known investor in India, has bought shares of a company called Mangalam Drugs and Organics Ltd.

This company has been doing poorly, with its stock price dropping by 80% over the past year.

Kedia believes that the company has good potential and is worth investing in, even though it is currently losing money.

He thinks that the company's assets, such as its manufacturing plants and products, are valuable and that the stock is undervalued.

However, investing in this company is risky because it is not making a profit and its stock price is very volatile.

Kedia's investment has caused the stock price to rise slightly, but it is still unclear if the company will be able to turn things around.

Sources